Helsinn Healthcare S.A., Petitioner v. Teva Pharmaceuticals USA, Inc., et al.

  1. July 02, 2019

    Supreme Court IP Recap: Patents

    The just-concluded U.S. Supreme Court term was quiet on the patent front, with only two decisions, but pending cases could put notable patent issues before the court in the coming months. Here's a look at the patent rulings from the last term and a preview of the next one.

  2. January 22, 2019

    High Court Says AIA Did Not Change Meaning Of On-Sale Bar

    The U.S. Supreme Court on Tuesday held the America Invents Act did not narrow the scope of the on-sale bar in patent cases, leaving unchanged a long-standing rule that confidential sales of an invention can be used to invalidate a patent.

  3. January 01, 2019

    Life Sciences Cases To Watch In 2019

    The life sciences industry will be keeping an eye on courtrooms around the country in 2019, watching to see how the U.S. Supreme Court decides a legal battle over patent protection for drugs and monitoring the fallout from federal prosecutors' decision to spike a False Claims Act case. Here are seven cases life sciences attorneys say they'll be following in the coming year.

  4. January 01, 2019

    Patent Cases To Watch In 2019

    The courts are set to tackle key patent issues like the on-sale bar rule, standing to seek or appeal America Invents Act reviews and whether patents issued before the AIA was passed can be challenged under the law. Here's a roundup of patent cases to watch in the coming year.

  5. December 04, 2018

    Justices Ask Tough Questions In AIA On-Sale Bar Case

    U.S. Supreme Court justices on Tuesday wrestled with the idea that the America Invents Act may have narrowed the on-sale bar in patent cases, while leaving open the door for a possible exception to the bar for activities that aren't commercial sales.

  6. November 30, 2018

    Up Next At High Court: AIA, Double Jeopardy

    The U.S. Supreme Court will examine patent eligibility under the America Invents Act, a securities enforcement action and a historic double jeopardy case when it returns to the bench Monday for the final week of arguments in 2018.

  7. November 08, 2018

    Helsinn Tells Justices Teva 'Badly Misconstrues' On-Sale Bar

    Helsinn on Thursday filed its final brief ahead of oral arguments next month in a U.S. Supreme Court case over the on-sale bar in patent cases, arguing that Teva's interpretation "badly misconstrues" the America Invents Act.

  8. October 16, 2018

    Policy Groups Back Teva In On-Sale Bar Case At High Court

    Two public policy groups have backed Teva Pharmaceuticals USA Inc. in its patent fight with Helsinn Healthcare SA over the nausea drug Aloxi, telling the U.S. Supreme Court that the latter's reading of the on-sale bar in patent cases would threaten the patent system and hinder public safety research.

  9. October 10, 2018

    Teva Tells Justices AIA Hasn't Changed On-Sale Bar Meaning

    Teva Pharmaceuticals USA Inc. lodged its brief in a case at the U.S. Supreme Court concerning the on-sale bar in patent cases, telling the justices the America Invents Act didn’t give the phrase “on sale” a new meaning that would reverse decades of legal precedent.

  10. October 09, 2018

    SG To Argue At Supreme Court For Limiting On-Sale Bar

    The U.S. Supreme Court on Tuesday cleared the solicitor general to argue at an upcoming case interpreting the America Invents Act's on-sale bar, allowing the government to throw its weight behind the petitioner who says the Federal Circuit dramatically expanded what counts as "on sale."